Clinical Trials in Salt Lake City

Showing 5561-5580 of 16,694 trials

A Drug-Drug Interaction Study of LY3537982 on Midazolam, Digoxin, and Rosuvastatin in Healthy Participants

NCT06111521

The main purpose of this study is to evaluate the effects of multiple doses of LY3537982 on the pharmacokinetics (PK) of digoxin (a P-glycoprotein \[P-gp\] substrate), rosuvastatin (a breast cancer resistance protein \[BCRP)\] substrate), and midazolam (a substrate of Cytochrome P450 3A4 \[CYP3A4\]) in adult healthy participants. The study will also evaluate the safety and tolerability of LY3537982 with or without single doses of digoxin, rosuvastatin, and midazolam. The study is conducted in two parts. Participants will stay in the research center during the study, which will last about 23 and 11 days for part 1 and part 2, respectively, not including screening.

Healthy

Eli Lilly and Company35 participantsStarted Oct 2023

Salt Lake City, Utah, United States

COMPLETEDPhase 1/2< 1 mile

Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies

NCT05364021

The objective of this study is to assess the safety, tolerability, efficacy, and pharmacokinetics of adjunctive therapy of LP352 in adults and adolescents with developmental and epileptic encephalopathies.

Developmental and Epileptic EncephalopathyDravet SyndromeLennox Gastaut Syndrome

Longboard Pharmaceuticals52 participantsStarted Mar 2022

Tucson, Arizona, United States • Little Rock, Arkansas, United States • Downey, California, United States +31 more locations

A Drug-Drug Interaction Study of LY3537982 on Midazolam, Digoxin, and Rosuvastatin in Healthy Participants

Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies

Find Trials by Condition in Salt Lake City

Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)

Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Syndrome

A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

A Study to Test Whether Taking BI 1358894 for 8 Weeks Helps Adults With Post-traumatic Stress Disorder

Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy

A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment

Study of Proton SBRT and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer

Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular Edema

Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions

Wound Assessment Using Spectral Imaging US

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas

Efficacy, Safety, Pharmacodynamic, and Pharmacokinetics Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency

Clinical Study to Evaluate the Safety and the Efficacy of EscharEx Drug Product (EX-03 Formulation) and Its Placebo Compared to Collagenase, Non-surgical Standard of Care, in Patients With Venous Leg Ulcers

Glyburide (RP-1127) for Traumatic Brain Injury (TBI)

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

A Study of Ipatasertib Plus Palbociclib and Fulvestrant Versus Placebo Plus Palbociclib and Fulvestrant in Hormone Receptor Positive and HER2 Negative Locally Advanced Unresectable or Metastatic Breast Cancer